Thursday, May 09, 2024 5:43:32 PM
https://ir.collegiumpharma.com/static-files/256cf28c-c774-44b0-82b5-e46427a28463
Recent COLL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:06:21 PM
- Collegium Reports Record Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/07/2024 09:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:01:24 PM
- Collegium Appoints Vikram Karnani as Chief Executive Officer • GlobeNewswire Inc. • 11/07/2024 09:01:00 PM
- Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024 • GlobeNewswire Inc. • 10/24/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 08:32:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 02:39:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 02:06:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2024 09:52:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/06/2024 03:53:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2024 08:47:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 12:03:46 PM
- Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/30/2024 12:00:00 PM
- Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024 • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/15/2024 08:05:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/12/2024 06:41:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/09/2024 08:34:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:04:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:01:35 PM
- Collegium Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/08/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 10:02:38 AM
- Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology • GlobeNewswire Inc. • 07/29/2024 10:00:00 AM
- Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024 • GlobeNewswire Inc. • 07/25/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 12:05:25 PM
- Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise • GlobeNewswire Inc. • 06/13/2024 12:00:00 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM